I'm here to take my lashes...
In all seriousness, the people who are worried about the stock have missed what I was saying since the beginning. Many of them were pulling for CLL approval, while i was in it for another reason...the Agenda Trial and a Tesetaxel partnership.
Over the past month, this stock has run up on speculation of approval in the treatment in CLL. I have to take some profits here as they have become unexpected gains from something that I never had my money on to begin with. That's that.
I hope this thing does get approved for the treatment of CLL. It has a shot and it very well could happen. I'm actually hoping that it does...because if that happens, sure I'll be late to the party and all you bastards will be celebrating on some beach somewhere, but it will mean certain completion of the Agenda Trial and likely a tesetaxel partnership, at that point the sky is literally the limit.
I hope I haven't discouraged too many people. My PERSONAL risk appetite met its threshold considering my ENTIRE portfolio. If I had other stocks that were performing as well as Genta, even if they were EVEN, I'd stay in this stock because I think it has a shot here shortly. I have to cover some of my losses on other plays as a trader. It doesn't mean that everyone should get out just because I do. Its my personal, holistic portfolio that is bleeding and this offsets my losses.
The DD that's out there hasn't changed, guys. If you are a believer in the approval of CLL then stay in the game. That's the bottom line. You could very, very well become a very wealthy person in a few days.
I'm a believer in the Agenda Trial, which is still a few months out...therefore, I had to take what I have here and bow out for a short time.
Either way, I'll be a buyer when results are released from the FDA on the approval/denial of Genasense in CLL. I'll be chasing like a mofo with approval when the bell rings (helping to skyrocket the price because I WILL buy a solid 2 penny's above the ask), or I'll be buying after the sell-off from those betting on approval in CLL.
I honestly hope that I'm chasing this bad boy down. If that's the case, this stock has no ceiling.
